| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Dec―04 |
The incidence and predisposing factors for irritable bowel syndrome following COVID-19: a systematic review and meta-analysis |
Yi-nuo Wang, Li-ying Zhou, Yu-Hong Huang, Min Jiang, Cong Dai |
| 2 |
[GO] |
2023―Sep―04 |
How we can improve the appropriateness of ambulatory gastrointestinal endoscopy: the lesson of the COVID-19 outbreak |
Antonio Tursi, Antonio Pio Palieri, Vincenzo Lattarulo, Antonio Elefante, Andrea Gigliobianco, Domenico Spinazzola, Walter Elisei, Alfredo Papa |
| 3 |
[GO] |
2023―Jul―28 |
Severe acute respiratory syndrome coronavirus 2 infection does not worsen the course of inflammatory bowel disease in the long term |
Benedetto Neri, Giorgia D’Agostini, Silvia Salvatori, Michelangela Mossa, Federica Bettin, Roberto Mancone, Irene Marafini, Elisabetta Lolli, Emma Calabrese, Giovanni Monteleone, Livia Biancone |
| 4 |
[GO] |
2023―Apr―28 |
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD) |
Mariabeatrice Principi, Fabio Salvatore Macaluso, Alessia Todeschini, Federica Facciotti, Antonella Contaldo, Fabiana Castiglione, Olga Maria Nardone, Rocco Spagnuolo, Patrizia Doldo, Gaia Riguccio, Francesco Simone Conforti, Chiara Viganò, Marta Ascolani, Gionata Fiorino, Carmen Correale, Giorgia Bodini, Monica Milla, Giulia Scardino, Marta Vernero, Federico Desideri, Flavio Caprioli, Mariella Mannino, Giuseppe Rizzo, Ambrogio Orlando |
| 5 |
[GO] |
2022―Dec―27 |
Humoral immunogenicity of COVID-19 vaccines in patients with coeliac disease and other noncoeliac enteropathies compared to healthy controls |
Davide Scalvini, Annalisa Schiepatti, Stiliano Maimaris, Emanuele Cosentini, Roberta Muscia, Virginia Gregorio, Elisa Roda, Federico Fassio, Paola Baiardi, Carlo Alessandro Locatelli, Federico Biagi |
| 6 |
[GO] |
2022―Sep―27 |
Comparison of liver function test- and inflammation-based prognostic scores for coronavirus disease 2019: a single center study |
Evangelos Cholongitas, Triada Bali, Vasiliki E Georgakopoulou, Aikaterini Kamiliou, Ioannis Vergos, Sotiria Makrodimitri, Stamatia Samara, Maria Triantafylou, Dimitrios Basoulis, Irene Eliadi, Georgios Karamanakos, Nikolaos V. Sipsas, Michael Samarkos |
| 7 |
[GO] |
2022―Aug―01 |
Gastrointestinal sequalae months after severe acute respiratory syndrome corona virus 2 infection: a prospective, observational study |
Peter Liptak, Martin Duricek, Robert Rosolanka, Ivana Ziacikova, Ivan Kocan, Peter Uhrik, Marian Grendar, Martina Hrnciarova, Patricia Bucova, David Galo, Peter Banovcin |
| 8 |
[GO] |
2022―Jul―08 |
SARS-CoV-2 infection as a potential trigger factor for de novo occurrence of inflammatory bowel disease |
Antonio Tursi, Loris Riccardo Lopetuso, Lorenzo Maria Vetrone, Antonio Gasbarrini, Alfredo Papa |
| 9 |
[GO] |
2022―Apr―28 |
Clinical features and predictive factors related to liver injury in SARS-CoV-2 Delta and Omicron variant-infected patients |
Haohui Deng, Haowei Lin, Yuzhen Mai, Huiyuan Liu, Weilie Chen |
| 10 |
[GO] |
2022―Mar―01 |
Rectal hematoma caused by colon rupture in a COVID-19 patient: a dreaded complication of infection |
Daphne J. Theodorou, Stavroula J. Theodorou, Maria G. Gianniki, Niki D. Tsifetaki, Ioannis V. Mitselos |
| 11 |
[GO] |
2022―Jan―20 |
Response to M. Amin: COVID-19 and the liver: overview |
Alexander Ng |
| 12 |
[GO] |
2021―Dec―03 |
Predictors of Covid-19 vaccination acceptance in IBD patients |
Anna Viola, Marco Muscianisi, Raffaele Li Voti, Giuseppe Costantino, Angela Alibrandi, Walter Fries |
| 13 |
[GO] |
2021―Nov―24 |
Assessment of proton-pump inhibitor use, race, socioeconomic status, and mortality in individuals with COVID-19 |
Elizabeth S. Aby, Manaswita Tappata, Holly Rodin, Jose D. Debes |
| 14 |
[GO] |
2021―Sep―25 |
The gut-liver axis in chronic liver disease associated with severe COVID-19 |
Jiezhong Chen, Luis Vitetta |
| 15 |
[GO] |
2021―Aug―17 |
The natural history of COVID-19 in patients with inflammatory bowel disease |
Giorgos Bamias, Georgios Kokkotis, Angeliki Christidou, Dimitrios K. Christodoulou, Vasileios Delis, Georgia Diamantopoulou, Smaragdi Fessatou, Anthia Gatopoulou, Olga Giouleme, Panagiota Kafritsa, Chrisostomos Kalantzis, Andreas Kapsoritakis, Pantelis Karatzas, Konstantinos Karmiris, Konstantinos Katsanos, Polyxeni Kevrekidou, Charalampos Kosmidis, Aikaterini Mantaka, Nicoletta Mathou, George Michalopoulos, Spyridon Michopoulos, Ioannis Papaconstantinou, George Papatheodoridis, Dimitrios Polymeros, Spyros Potamianos, Georgios Poulopoulos, Andreas Protopapas, Maria Sklavaina, Konstantinos Soufleris, Georgios Theocharis, Angeliki Theodoropoulou, John K. Triantafillidis, Konstantinos Triantafyllou, Georgia Tsiolakidou, Eftychia Tsironi, Maria Tzouvala, Nikos Viazis, Vasileios Xourgias, Eirini Zacharopoulou, Evanthia Zampeli, Gerasimos J. Mantzaris |
| 16 |
[GO] |
2021―Aug―16 |
‘Scope’ of acute esophageal obstruction in the era of COVID-19 |
Hemant Goyal, Abhilash Perisetti, Mahesh Gajendran, Aman Ali, Neil R. Sharma |
| 17 |
[GO] |
2021―Jul―02 |
SARS-COV2 and eosinophilic esophagitis: a first case |
Maurizio Mennini, Francesca Rea, Carla Riccardi, Paola De Angelis, Renato Tambucci |
| 18 |
[GO] |
2021―Jun―30 |
Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome |
Vered Richter, Anton Bermont, Daniel L Cohen, Efrat Broide, Haim Shirin |
| 19 |
[GO] |
2021―Jun―16 |
Management of gastrointestinal bleeding during COVID-19 |
Hemant Goyal, Sonali Sachdeva, Abhilash Perisetti, Rupinder Mann, Saurabh Chandan, Sumant Inamdar, Benjamin Tharian |
| 20 |
[GO] |
2021―May―09 |
Laboratory manifestations and pathophysiological aspects of coronavirus disease 2019 pandemic |
Michail Galanopoulos, Grigorios Karianakis, Kyriakos Amorginos, Aris Doukatas, Filippos Gkeros, Nikolaos Tsoukalas, Ioannis Papanikolaou, Nikos Viazis, Christos Liatsos |
| 21 |
[GO] |
2021―Apr―02 |
Gastrointestinal endoscopy can be safely performed during pandemic SARS-CoV-2 infection in Central Italy |
Emanuele Dilaghi, Adriano Marcolongo, Paolo Anibaldi, Maurizio Simmaco, Claudio Prestigiacomo, Stefano Angeletti, Vito D. Corleto, Giancarlo D’Ambra, Maurizio Ruggeri, Emilio Di Giulio, Bruno Annibale, Edith Lahner |
| 22 |
[GO] |
2021―Mar―31 |
Clinical course and outcome among patients with acute pancreatitis and COVID-19 |
Vivek Kumar, Ebrahim Barkoudah, Daniel A.T. Souza, David X. Jin, Julia McNabb-Baltar |
| 23 |
[GO] |
2021―Mar―31 |
Gastrointestinal manifestations of COVID-19: results from a European centre |
Tiago Leal, Emanuel Costa, Bruno Arroja, Raquel Gonçalves, Joana Alves |
| 24 |
[GO] |
2021―Mar―20 |
Safety and protection in endoscopic services during phase II of COVID-19 pandemic |
Roberto Vassallo, Ludovica Venezia, Angelo Zullo, Elisa Stasi, Giuseppe Milazzo, Marco Soncini, Omero Triossi, Francesco Neri Bortoluzzi, Paolo Montalto, Paolo Usai Satta, Fabio Monica |
| 25 |
[GO] |
2021―Mar―03 |
The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection |
Yana Davidov-Derevynko, Gil Ben Yakov, Anat Wieder, Gad Segal, Lior Naveh, Natalia Orlova, Irina Gringauz, Sharon Amit, Orna Mor, Robert Klempfner, Galia Rahav, Ziv Ben Ari |
| 26 |
[GO] |
2021―Feb―27 |
Alanine aminotransferase serum levels in COVID-19 patients inversely correlate with SARS-CoV-2 antigen |
Erasmia Rouka, Ourania S. Kotsiou, Garyfallia Perlepe, Athanasios Pagonis, Ioannis Pantazopoulos, Konstantinos I. Gourgoulianis |
| 27 |
[GO] |
2021―Feb―27 |
Fibrosis-4 index and mortality in coronavirus disease 2019 |
Raymond Pranata, Emir Yonas, Ian Huang, Michael Anthonius Lim, Sally Aman Nasution, Raden Ayu Tuty Kuswardhani |
| 28 |
[GO] |
2021―Feb―21 |
Severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortality |
Sanjaya K. Satapathy, Christian Kuntzen, He Qiu, Yu Jiang, Henry C. Bodenheimer, Nitzan C. Roth, Tai-Ping Lee, Jamie S. Hirsch, Arvind J. Trindade, David E. Bernstein |
| 29 |
[GO] |
2021―Jan―30 |
Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease |
Susanna Scharrer, Maximilian Kutschera, Lukas Weseslindtner, Christian Primas, Harald Vogelsang |
| 30 |
[GO] |
2021―Jan―27 |
Stress-related consequences of the coronavirus disease 2019 pandemic on symptoms of Crohn’s disease |
Sarah M. Goodday, Simon Travis, Alissa Walsh, Stephen H. Friend |
| 31 |
[GO] |
2021―Jan―20 |
Gastrointestinal symptoms are associated with severity of coronavirus disease 2019 |
Weibiao Zeng, Kai Qi, Miao Ye, Li Zheng, Xinliang Liu, Sheng Hu, Wenxiong Zhang, Wenjing Tang, Jianjun Xu, Dongliang Yu, Yiping Wei |
| 32 |
[GO] |
2021―Jan―13 |
Cytokine-induced liver injury in coronavirus disease-2019 (COVID-19) |
Prajna Anirvan, Sonali Narain, Negin Hajizadeh, Fuad Z . Aloor, Shivaram P. Singh, Sanjaya K. Satapathy |
| 33 |
[GO] |
2021―Jan―05 |
Prevalence, incidence and clinical features of SARS-CoV-2 infection in adult coeliac patients |
Annalisa Schiepatti, Eleonora Alimenti, Stiliano Maimaris, Maria Luisa Nicolardi, Francesca Manzella La Barbera, Paola Baiardi, Federico Biagi |
| 34 |
[GO] |
2020―Dec―24 |
The liver in COVID-19 |
Harsh Goel, Farah Harmouch, Kawish Garg, Pooja Saraiya, Timothy Daly, Ashish Kumar, John T. Hippen |
| 35 |
[GO] |
2020―Nov―29 |
Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19 |
Preethi Ramachandran, Abhilash Perisetti, Mahesh Gajendran, Farla Jean-Louis, Pardeep Bansal, Alok Kumar Dwivedi, Hemant Goyal |
| 36 |
[GO] |
2020―Nov―02 |
COVID-19 |
Mengna Zhang, Yunjiao Zhou, Haiou Li, Yanan Peng, Peishan Qiu, Xianyan Shi, Xingfei Pan, Jing Liu |
| 37 |
[GO] |
2020―Nov―02 |
The indicative role of markers for liver injury on the severity and prognosis of coronavirus disease 2019 patients |
Rongrong Yang, Xien Gui, Hengning Ke, Shicheng Gao, Mingqi Luo, Yong Xiong |
| 38 |
[GO] |
2020―Oct―24 |
Eosinophilic esophagitis: is the Th2 inflammation protective against the severe form of COVID-19? |
Laura Franceschini, Raffaele Macchiarelli, Silvia Rentini, Ivano Biviano, Alessandro Farsi |
| 39 |
[GO] |
2020―Oct―08 |
Liver injury could be associated with severe disease in COVID-19 patients |
Chuan Liu, Jiahui Yang, Wancong Wang, Pengyuan Zheng, Youcai Tang |
| 40 |
[GO] |
2020―Sep―25 |
High level of defensin alpha 5 in intestine may explain the low incidence of diarrhoea in COVID-19 patients |
Junwen Luan, Yongwen Ren, Shan Gao, Leiliang Zhang |
| 41 |
[GO] |
2020―Sep―25 |
Patient’s perspective on the implementation of measures to contain the SARS-CoV-2 pandemic in a Portuguese Gastroenterology Department |
Catarina Gomes, Rolando Pinho, Ana Ponte, João Carlos Silva, Edgar Afecto, João Correia, João Carvalho |
| 42 |
[GO] |
2020―Sep―20 |
Epidemiological approximation of the enteric manifestation and possible fecal-oral transmission in COVID-19 |
Javier Pamplona, Rubén Solano, Cristina Soler, Miriam Sabat |
| 43 |
[GO] |
2020―Sep―20 |
ESPGHAN ‘biopsy-sparing’ guidelines for celiac disease in children with low antitransglutaminase during COVID-19 |
Chiara Maria Trovato, Monica Montuori, Salvatore Cucchiara, Salvatore Oliva |
| 44 |
[GO] |
2020―Sep―13 |
Primary presentation of COVID-19 solely with gastrointestinal symptoms |
Christoph G. Dietrich, Dolores Hübner, Gernot Marx, Johannes Bickenbach, Andreas Bootsveld |
| 45 |
[GO] |
2020―Aug―30 |
Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome |
Mahmud Mahamid, Wiliam Nseir, Tawfik Khoury, Baker Mahamid, Adi Nubania, Kamal Sub-Laban, Joel Schifter, Amir Mari, Wisam Sbeit, Eran Goldin |
| 46 |
[GO] |
2020―Aug―13 |
Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection |
Christian Labenz, Gerrit Toenges, Marcus-Alexander Wörns, Martin F. Sprinzl, Peter R. Galle, Jörn M. Schattenberg |
| 47 |
[GO] |
2020―Aug―10 |
Efficacy of endoscopic triage during the Covid-19 outbreak and infective risk |
Luca Elli, Gian Eugenio Tontini, Elisabetta Filippi, Lucia Scaramella, Paolo Canté, Maurizio Vecchi, Roberto Bertè, Annarita Baldassarri, Roberto Penagini |
| 48 |
[GO] |
2020―Aug―10 |
Is emergency endoscopic retrograde cholangiopancreatography safe in COVID-19 pandemic? |
Murat Kekilli, Benan Kasapoglu, Buket Cigdem Sahin, Ahmet Yozgat |
| 49 |
[GO] |
2020―Jul―29 |
COVID-19 and celiac disease - concerns to be addressed |
Isabel Garrido, Armando Peixoto, Guilherme Macedo |
| 50 |
[GO] |
2020―Jul―10 |
Multidetector computed tomography chest findings of coronavirus disease 2019 pneumonia in patient with hepatocellular carcinoma |
Adel El-Badrawy |
| 51 |
[GO] |
2020―Jul―08 |
COVID-19 |
Jean-François Cadranel, Noémi Reboux, Jean-Baptiste Nousbaum |
| 52 |
[GO] |
2020―Jul―08 |
COVID-19 and liver injury |
Karn Wijarnpreecha, Patompong Ungprasert, Panadeekarn Panjawatanan, Denise M. Harnois, Himesh B. Zaver, Aijaz Ahmed, Donghee Kim |
| 53 |
[GO] |
2020―Jun―19 |
COVID-19 and the liver |
Mona Amin |
| 54 |
[GO] |
2020―Jun―19 |
Covid-19 infection, liver injury and prognosis |
Gianni Testino |
| 55 |
[GO] |
2020―Jun―19 |
Case series and review of liver dysfunction in COVID-19 patients |
Pujitha Kudaravalli, Sheikh A Saleem, Bashar Ibeche, Savio John |
| 56 |
[GO] |
2020―Jun―15 |
Immune monitoring of a child with autoimmune hepatitis and type 1 diabetes during COVID-19 infection |
Muhammed Yuksel, Hacer Akturk, Cigdem Arikan |
| 57 |
[GO] |
2020―Jun―05 |
Implications of COVID-19 for the busy gastroenterologist |
Joel Ferreira-Silva, Armando Peixoto, Eduardo Rodrigues-Pinto, Guilherme Macedo |
| 58 |
[GO] |
2020―Jun―05 |
Kinetic patterns of liver enzyme elevation with COVID-19 in the USA |
Ben L. Da, Robert A. Mitchell, Brian T. Lee, Ponni Perumalswami, Gene Y. Im, Ritu Agarwal, Thomas D. Schiano, Douglas Dieterich, Behnam Saberi |
| 59 |
[GO] |
2020―May―26 |
Dangerous interactions of gastrointestinal drugs with experimental treatments for COVID-19 |
Kamran B. Lankarani |
| 60 |
[GO] |
2020―Apr―13 |
Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19) |
Giuseppe Lippi, Maria Helena Santos de Oliveira, Brandon Michael Henry |
|
